Exelixis (EXEL) Net Equity Issued and Repurchased (2010 - 2026)
Exelixis (EXEL) reported Net Equity Issued and Repurchased of $15.44 million for Q2 2027, down 40.8% from $26.08 million a year earlier but up 106.6% from the prior quarter.
Exelixis (EXEL) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Over the twelve months ended Jul 3, 2026, Exelixis' Net Equity Issued and Repurchased came in at $34.34 million, down 55.0% year-over-year; for FY2026, it came in at $49.14 million, down 20.6% from FY2025.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 15.1% (FY2021 to FY2026).
- By year, Net Equity Issued and Repurchased came in at $61.85 million in FY2025, $33.45 million in FY2023 (+40.0%) and $23.89 million in FY2022 (-1.7%).
- Five-year quarterly Net Equity Issued and Repurchased spans a low of $3.55 million in Q3 2026 and a high of $26.08 million in Q2 2026.
- Year over year, Net Equity Issued and Repurchased has now declined in each of the last four quarters, with an average decline of 17.0% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2027 came in at $7.47 million (Q1 2027), $7.88 million (Q4 2026) and $3.55 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn | 15.44 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 15.44 Mn |
| Apr 3, 2026 | 7.47 Mn |
| Jan 2, 2026 | 7.88 Mn |
| Oct 3, 2025 | 3.55 Mn |
| Jul 4, 2025 | 26.08 Mn |
| Apr 4, 2025 | 11.63 Mn |
| Jan 3, 2025 | 18.82 Mn |
| Sep 27, 2024 | 19.79 Mn |
| Jun 28, 2024 | 14.92 Mn |
| Mar 29, 2024 | 8.32 Mn |
| Dec 29, 2023 | 9.11 Mn |
| Sep 29, 2023 | 6.92 Mn |
| Jun 30, 2023 | 10.28 Mn |
| Mar 31, 2023 | 7.14 Mn |
| Dec 30, 2022 | 5.21 Mn |
| Sep 30, 2022 | 2.89 Mn |
| Jul 1, 2022 | 10.90 Mn |
| Apr 1, 2022 | 4.89 Mn |
| Dec 31, 2021 | 6.07 Mn |
| Oct 1, 2021 | 2.76 Mn |
Exelixis Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EXEL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();